We are live on ! Find out more
ESPR

Esperion Therapeutics
ESPR

Delisted

ESPR was delisted on the 10th of July, 2026.

187 hedge funds and large institutions have $1.91B invested in Esperion Therapeutics in 2018 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 69 increasing their positions, 54 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

135% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 17

28% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 54

20% more capital invested

Capital invested by funds: $1.6B → $1.91B (+$319M)

13% more funds holding

Funds holding: 165187 (+22)

7.25% more ownership

Funds ownership: 92.75%100% (+7.2%)

13% less funds holding in top 10

Funds holding in top 10: 87 (-1)

36% less call options, than puts

Call options by funds: $83.1M | Put options by funds: $130M

Holders
187
Holders Change
+22
Holders Change %
+13.33%
% of All Funds
4.29%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.16%
New
40
Increased
69
Reduced
54
Closed
17
Calls
$83.1M
Puts
$130M
Net Calls
-$46.6M
Net Calls Change
-$49.3M
Name Holding Trade Value Shares
Change
Change in
Stake
STA
201
Summit Trail Advisors
New York
-$101K -1,450 Closed
Pacer Advisors
202
Pacer Advisors
Pennsylvania
-$92K -1,400 Closed
PCM
203
Prelude Capital Management
New York
-$33K -500 Closed
BFEC
204
Benjamin F. Edwards & Company
Missouri
-$10K -152 Closed